ODT
Income statement / Annual
Last year (2020), Odonate Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2020, Odonate Therapeutics, Inc.'s net income was -$126.35 M.
See Odonate Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$117.04 M
|
$104.03 M
|
$79.95 M
|
$27.90 M
|
$2.62 M
|
$0.00
|
| General & Administrative Expenses |
$10.39 M
|
$10.90 M
|
$10.82 M
|
$4.84 M
|
$463.00 K
|
$158.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.39 M
|
$10.90 M
|
$10.82 M
|
$4.84 M
|
$463.00 K
|
$158.00 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$316.00 K
|
| Operating Expenses |
$127.43 M
|
$114.93 M
|
$90.76 M
|
$32.74 M
|
$3.09 M
|
-$158.00 K
|
| Cost And Expenses |
$127.43 M
|
$114.93 M
|
$90.76 M
|
$32.74 M
|
$3.09 M
|
$158.00 K
|
| Interest Income |
$0.00
|
$3.11 M
|
$1.80 M
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$445.00 K
|
$381.00 K
|
$350.00 K
|
$20.00 K
|
$22.82 K
|
$0.00
|
| EBITDA |
-$126.99 M |
-$111.44 M |
-$88.61 M |
-$32.72 M |
-$3.09 M |
-$158.00 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.08 M
|
$3.11 M
|
$1.80 M
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$126.35 M
|
-$111.83 M
|
-$88.96 M
|
-$32.74 M
|
-$3.09 M
|
-$158.00 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$126.35 M
|
-$111.83 M
|
-$88.96 M
|
-$32.74 M
|
-$3.09 M
|
-$158.00 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-3.85 |
-4.05 |
-3.64 |
-1.28 |
-0.11 |
-0.0059 |
| EPS Diluted |
-3.85 |
-4.05 |
-3.64 |
-1.28 |
-0.11 |
-0.0059 |
| Weighted Average Shares Out |
$32.82 M
|
$27.63 M
|
$24.46 M
|
$25.62 M
|
$26.89 M
|
$26.89 M
|
| Weighted Average Shares Out Diluted |
$32.82 M
|
$27.63 M
|
$24.46 M
|
$25.62 M
|
$26.89 M
|
$26.89 M
|
| Link |
|
|
|
|
|
|
